sprite-preloader
Anzeige
Mehr »
Freitag, 27.04.2018 Börsentäglich über 12.000 News von 575 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen
17.04.2018 | 15:04
(9 Leser)
Schrift ändern:
(0 Bewertungen)

PR Newswire·Mehr Nachrichten von PR Newswire

LONDON, April 17, 2018 /PRNewswire/ --

Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), Other Applications

Report Details

The neuromodulation devices market is estimated to grow at a CAGR of 11.7% in the first half of the forecast period. The Spinal Cord Stimulation (SCS) submarket is estimated to account for 43.6% share of this market in 2018.

(Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new221-page reportyou will receive125 charts- all unavailable elsewhere.

The 221-page report provides clear detailed insight into the global neuromodulation devices market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

•Global Neuromodulation Devices market forecastsfrom2018-2028

• This report also breaks down the revenue forecast for the global neuromodulation devices marketby type:
• Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS)
• Vagus Nerve Stimulation (VNS)
• Sacral Nerve Stimulation (SNS)
• Gastric Electrical Stimulation (GES)
• Other Applications

This report discusses themarket trendsand lists theleading products/pipeline productsof each submarket.

• This report provides individual revenue forecasts to 2028 for theseregional and national markets:
North America: the US and Canada
Europe: France, Germany, Italy, U.K, Spain, Russia, Rest of Europe
Asia-Pacific: Japan, China, India, Australia, South Korea and rest of Asia-Pacific
Latin America: Brazil, Mexico, Rest of Latin America
• Rest of the World: Middle East, Africa

Each regional market isfurther segmented by type of applications: Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), Other Applications

• Our study givesqualitative analysisof the neuromodulation devices market. It discusses the factors thatdriveandrestrainthe neuromodulation devices market. This study also provides aSWOTandSTEPanalysis.

• Our study discusses theselected leading companiesthat are the major players in the neuromodulation devices industry:
• Medtronic
• Boston Scientific
• St Jude Medical (Abbott)
• Cyberonics (LivaNova)
• Stryker Corporation
• Nevro Corp.
• SetPoint Medical
• Functional Neuromodulation
• Neurotherapies Reset
• Wringless Implantable Stretchable Electronics (WISE)
• SceneRay
• Mindray

Visiongain's study is intended for anyone requiring commercial analyses for the global neuromodulation devices market. You find data, trends and predictions.

Buy our report todayGlobal Neuromodulation Devices Report 2018-2028: Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), Other Applications.

To request a report overview of this report, please email Sara Peerun at sara.peerun@visiongain.com or call Tel: +44-(0)-20-7336-6100

Or click on: https://www.visiongain.com/Report/2165/Global-Neuromodulation-Devices-Report-2018-2028

List of Companies Mentioned in the Report

Abbott

Accellent

Advanced Uro-Solutions

Aleva Neurotherapeutics

Atrotech

Autonomic Technologies

Avery Biomedical

Axonics Modulation

Bard Electrophysiology

Bayer AG

BioControl Medical

Bioness, Inc.

BlueWind

Boston Scientific

CardioMEMS

Cerbomed GmbH

CerebralRx

CerebroMed

Cogentix Medical

Covidien

CVRx, Inc

Cyberonics

DBI

Deep Brain Innovations

electroCore

EndoNovo

EndoStim Inc

Enopace Biomedical

EnteroMedics

Functional Neuromodulation

Genesys Capital

Greatbatch

Halo Neuroscience

ImThera Medical

ImThera Medical, Inc.

InCube Labs

Integer Holdings Corporation

IoGyn, Inc.

Laborie Medical Technologies

Lake Region Medical

LivaNova

MagStim

MainStay Medical

Medtronic

Medtronic Eindhoven Design Centre (MEDC)

Medtronic International Trading Sarl

MedtronicNeuro

MetaCure

Metavention

Microtransponder

Mindray

Nanostim

NDI Medical

NeuImpulse

NeuroPace

NeuroSigma

NeuroStar

Neurotherapies Reset

NeuroTherm

NeuroVista Corp

NeuSpera

Nevro

Newronika

Nexstim plc

nUro Inc

Nuvectra Corporation

QiG Group,LLC

Rio Grande

Sapiens SBS

Sapiens Steering Brain Stimulation

SceneRay

Scion NeuroStim

SetPoint Medical

Sorin

SorinSpA

Soterix Medical

Spinal Modulation Inc

SPR Therapeutics

St. Jude Medical

StarMedTec

StimGuard, LLC.

Stimwave

Stryker Corporation

Synapse Medical

Urolplasty

To see a report overview please email Sara Peerun on sara.peerun@visiongain.com


© 2018 PR Newswire